We are a venture firm based in New York City and Silicon Valley investing in counter-conventional, seed and early stage science and technology ventures. The firm manages $700 million in assets across four funds.
We invest in what matters, launching companies that can change the world while offering the potential for extraordinary investment returns: from cancer therapies, to petroleum replacements, to new vaccines. We are indifferent to short-term vicissitudes and market volatility, and long on human ingenuity. The ingredients we help assemble are big breakthroughs, passionate entrepreneurs, transformative technologies, and massive markets.
Lux founded strategic holdings in media, research and policy as proprietary sources of intelligence, access and influence – ensuring that our portfolio companies are better connected, have deeper insight, and command industry leadership faster than their competition.